ISCO

OQB International Stem Cell Corporation
Oct 12, 2026 · 10:37 PM ET EOD Market Closed

$0.2800 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2800, and at the day’s high of $0.2800

YTD change
+100.00%
vs 20-day SMA
-12.40%
vs 200-day SMA
+37.43%

Price ranges

Previous day
$0.2800 $0.2850
open $0.2850 close $0.2800
-$0.0050 (-1.75%)
Today
$0.2750 $0.2800
open $0.2750 now $0.2800
+$0.0050 (+1.82%)
Past week
$0.2609 $0.2900
from $0.2900 now $0.2800
-$0.0100 (-3.45%)
Past month
$0.2609 $0.5200
from $0.3663 now $0.2800
-$0.0863 (-23.55%)
This year
$0.1170 $0.5400
from $0.1400 now $0.2800
+$0.1400 (+100.00%)

Price & Performance

+0.13 (+86.67%) / 6M

$0.1102$0.2541$0.3980$0.5419Apr 15Aug 5Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.9% away from all-time highs of $525.0000
  • ISCO is up 100% since the beginning of the year
  • ISCO is up 114% over the past 12 months
  • ISCO is down 24% over the past 1 month

ISCO reads not so good: price sits above one of the two key moving averages, the 12-month move is +89.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.0084
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $8.4M
Beta 0.01

Balance sheet & scale

IncomeN/A
Revenue$9.2M
Cash$920.0K
Debt$3.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeOQB
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $2.2M

International Stem Cell Corp. operates as a research and development company for the therapeutic market. It focuses on advancing potential clinical applications of human parthenogenetic stem cells for the treatment of various diseases of the central nervous system and liver diseases. The firm operates through three segments: Therapeutic Market, Biomedical Market and Anti-Aging Market. The Biomedical Market segment markets and sells primary human cell research products with two product categories, cells and media. The Anti-Aging market segment markets and sells a line of skincare products sold through two sales channels: ecommerce and professional. The ecommerce channel sells direct to customers through online orders, while professional sales are to spas, salons and other skincare providers. The Therapeutic Market segment focuses on the research and development of human parthenogenetic stem cells for the treatment of diseases of the central nervous system, liver diseases and is currently conducting clinical trials for the treatment of Parkinson's disease. The company was founded by William B. Adams, Kenneth C. Aldrich and Gregory S. Keller in June 2005 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $762.81 +2.18%
IQV IQVIA Holdings Inc $262.21 +0.90%
CRL Charles River Laboratories International, Inc. $301.86 +0.02%
IT Gartner, Inc. $194.10 +1.54%
ICLR ICON Plc $164.40 +0.14%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.